216 related articles for article (PubMed ID: 24532745)
1. Drug therapies in dermatology.
Aslam A; Griffiths CE
Clin Med (Lond); 2014 Feb; 14(1):47-53. PubMed ID: 24532745
[TBL] [Abstract][Full Text] [Related]
2. Dermatology update: The dawn of targeted treatment.
Fernandez A
Cleve Clin J Med; 2015 May; 82(5):309-20. PubMed ID: 25973879
[TBL] [Abstract][Full Text] [Related]
3. A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013 - Istanbul, Turkey).
Rabasseda X
Drugs Today (Barc); 2013 Oct; 49(10):667-77. PubMed ID: 24191258
[TBL] [Abstract][Full Text] [Related]
4. Review of Targeted Therapies for Periocular Tumors.
Mehta VJ; Ling J; Sobel RK
Int Ophthalmol Clin; 2017; 57(1):153-168. PubMed ID: 27898621
[No Abstract] [Full Text] [Related]
5. New therapies in pediatric dermatology.
Lofgren S; Krol A
Curr Opin Pediatr; 2011 Aug; 23(4):399-402. PubMed ID: 21602678
[TBL] [Abstract][Full Text] [Related]
6. [Dermatologic treatment. The Danish Society of Dermatology].
Olesen AK; Jemec GB
Ugeskr Laeger; 2003 Mar; 165(12):1228. PubMed ID: 12701278
[No Abstract] [Full Text] [Related]
7. [Cytokines: current status and prospects in the treatment of skin tumors].
Nashan D; Luger TA
Hautarzt; 2001 Aug; 52(8):691-6. PubMed ID: 11544938
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate and its uses in dermatology.
Jetton RL
Med Times; 1970 Jun; 98(6):83-92. PubMed ID: 4910984
[No Abstract] [Full Text] [Related]
9. Skin cancer treatment options: new horizons and promises for the future.
Semkova K; Tchernev G; Wollina U
Wien Med Wochenschr; 2013 Aug; 163(15-16):345-6. PubMed ID: 23846703
[No Abstract] [Full Text] [Related]
10. [What's new in dermatological treatments?].
Martin L
Ann Dermatol Venereol; 2010 Dec; 137 Suppl 4():S165-76. PubMed ID: 21193120
[TBL] [Abstract][Full Text] [Related]
11. Changing pathology with changing drugs: skin cancer.
Karpova MB; Barysch MJ; Zipser MC; Schönewolf N; French LE; Dummer R
Pathobiology; 2011; 78(2):61-75. PubMed ID: 21677470
[TBL] [Abstract][Full Text] [Related]
12. [Experiences with a cytostaticly active ointment in the dermatologic practice. (5 per cent--5-fluorouracil ointment)].
Weitgasser H
Wien Med Wochenschr; 1969 Mar; 119(13):253-5. PubMed ID: 5767544
[No Abstract] [Full Text] [Related]
13. Retinoids in the management of non-melanoma skin cancer and melanoma.
Craven NM; Griffiths CE
Cancer Surv; 1996; 26():267-88. PubMed ID: 8783579
[No Abstract] [Full Text] [Related]
14. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.
Mortlock RD; Ma EC; Cohen JM; Damsky W
J Invest Dermatol; 2023 Aug; 143(8):1412-1422. PubMed ID: 37341663
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of malignant lesions of the skin.
Hardin WJ
Tex Med; 1973 Apr; 69(4):87-92. PubMed ID: 4693371
[No Abstract] [Full Text] [Related]
16. [THE CUTANEOUS UPTAKE OF P-32 IN DERMATOLOGICAL ANALYSIS].
BONELLI M; ALE G
G Ital Dermatol; 1964; 105():243-80. PubMed ID: 14168582
[No Abstract] [Full Text] [Related]
17. American Academy of Dermatology-68th annual meeting. 5-9 March 2010, Miami Beach, FL, USA.
Whang T; Goldenberg G
IDrugs; 2010 May; 13(5):311-3. PubMed ID: 20432186
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experience with NK 631 in malignant tumors of skin (author's transl)].
Nobe O; Kubo H; Yoshii K; Tashiro M
Jpn J Antibiot; 1979 Mar; 32(3):463-9. PubMed ID: 86628
[TBL] [Abstract][Full Text] [Related]
19. The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders.
Nguyen QD; Starling CT; Hebert AA
Paediatr Drugs; 2020 Jun; 22(3):311-319. PubMed ID: 32350817
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications for topical 5-fluorouracil in the treatment of dermatological disorders.
Moore AY
J Dermatolog Treat; 2009; 20(6):328-35. PubMed ID: 19954388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
